Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 15, 2023
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
Ami Fadia Reiterated (BCYC) at Strong Buy and Held Target at $72 on, Feb 15th, 2023
Ami Fadia of Needham, Reiterated "Bicycle Therapeutics plc" (BCYC) at Strong Buy and Held Target at $72 on, Feb 15th, 2023.
Ami has made no other calls on BCYC in the last 4 months.
There is 1 other peer that has a rating on BCYC. Out of the 1 peers that are also analyzing BCYC, 0 agree with Ami's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ami
- Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Wednesday, November 9th, 2022
